A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Erasca, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 793,200 shares of ERAS stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
793,200
Previous 843,300 5.94%
Holding current value
$2.01 Million
Previous $1.99 Million 8.79%
% of portfolio
0.01%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.17 - $3.28 $108,717 - $164,328
-50,100 Reduced 5.94%
793,200 $2.17 Million
Q2 2024

Aug 14, 2024

SELL
$1.79 - $2.63 $344,754 - $506,538
-192,600 Reduced 18.59%
843,300 $1.99 Million
Q1 2024

May 15, 2024

BUY
$1.67 - $2.55 $683,698 - $1.04 Million
409,400 Added 65.35%
1,035,900 $2.13 Million
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.49 $223,613 - $333,411
133,900 Added 27.18%
626,500 $1.33 Million
Q3 2023

Nov 14, 2023

SELL
$1.97 - $2.91 $297,076 - $438,828
-150,800 Reduced 23.44%
492,600 $970,000
Q2 2023

Aug 14, 2023

BUY
$2.57 - $3.3 $547,924 - $703,560
213,200 Added 49.56%
643,400 $1.78 Million
Q1 2023

May 15, 2023

BUY
$2.74 - $4.44 $1.08 Million - $1.75 Million
394,600 Added 1108.43%
430,200 $1.29 Million
Q4 2022

Feb 14, 2023

BUY
$3.89 - $8.57 $138,484 - $305,092
35,600 New
35,600 $153,000

Others Institutions Holding ERAS

About Erasca, Inc.


  • Ticker ERAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 122,147,000
  • Market Cap $310M
  • Description
  • Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...
More about ERAS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.